Differentiated product
Tacrolimus
Ready-to-use injectable solution · Graft-rejection prevention in HSCT
Product data
- Dosage form
- Ready-to-use injectable solution
- Dosage-form group
- Injectable
- Therapeutic area
- Graft-rejection prevention in HSCT
- Reference product
- Injectable solution 5 mg/mL
- KMS approach
- Design-around composition for stability
- Status
- Ready for technology transfer
- Development stage
- 4 of 5 · Ready for tech transfer
- Portfolio
- Differentiated product
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23